Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials

BACKGROUND: Pulmonary arterial hypertension (PAH) is a devastating disease and ultimately leads to right heart failure and premature death. A total of four classical targeted drugs, prostanoids, endothelin receptor antagonists (ERAs), phosphodiesterase 5 inhibitors (PDE-5Is), and soluble guanylate c...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiao-Fei, Zhang, Jun-Jie, Jiang, Xiao-Min, Ge, Zhen, Wang, Zhi-Mei, Li, Bing, Mao, Wen-Xing, Chen, Shao-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428768/
https://www.ncbi.nlm.nih.gov/pubmed/28507431
http://dx.doi.org/10.2147/PPA.S133288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428768/
https://www.ncbi.nlm.nih.gov/pubmed/28507431
http://dx.doi.org/10.2147/PPA.S133288

Ejemplares similares